Article Versions Notes

Ballesté-Delpierre C, Ramírez Á, Muñoz L, Longshaw C, Roca I, Vila J. Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates. Antibiotics. 2022; 11(2):187. https://doi.org/10.3390/antibiotics11020187

Ballesté-Delpierre, Clara, Ángel Ramírez, Laura Muñoz, Christopher Longshaw, Ignasi Roca, and Jordi Vila. 2022. "Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates" Antibiotics 11, no. 2: 187. https://doi.org/10.3390/antibiotics11020187

Ballesté-Delpierre, C., Ramírez, Á., Muñoz, L., Longshaw, C., Roca, I., & Vila, J. (2022). Assessment of In Vitro Cefiderocol Susceptibility and Comparators against an Epidemiologically Diverse Collection of Acinetobacter baumannii Clinical Isolates. Antibiotics, 11(2), 187. https://doi.org/10.3390/antibiotics11020187